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Results Ten topics were considered in this guideline, 
including amongst others, the different approaches for hys-
terectomy, advice regarding tissue extraction, pre-operative 
medical treatment and prevention of ureter injury. This 
work resulted in the development of a clinical practical 
guideline of LH with evidence- and expert-based recom-
mendations. The guideline is currently being implemented 
in The Netherlands.
Conclusion A guideline for LH was developed. It gives 
an overview of best clinical practice recommendations. It 
serves to standardize care, provides guidance for daily prac-
tice and aims to guarantee the quality of LH at an (inter)
national level.
Keywords Laparoscopic hysterectomy · Clinical practice 
guideline · Best practice · AGREE II tool · GRADE 
method
Introduction
Since the introduction of laparoscopic hysterectomy (LH) 
more than 2 decades ago, a rapid implementation of this 
procedure has been observed in many countries [1, 2]. For 
The Netherlands, the percentage of hysterectomies per-
formed laparoscopically has increased from 3% in 2002 to 
36% in 2012 [3] and similar increases have been observed 
in other parts of the world [1, 2]. Such rapid implementa-
tion can potentially result in unwarranted practice varia-
tions in health care delivery [4]. Unexplained differences in 
health care delivery should be addressed as they are usu-
ally the consequence of a lack of consensus and/or avail-
able evidence [5, 6]. Without a convenient standard of care, 
doctors are more prone to adopt medical practices that are 
based on personal experience [5, 6]. Furthermore, studies 
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have shown that standardizing care on best practices is 
associated with better outcomes and reduced costs [7]. As 
a result, it seems timely to define a standard of care for LH, 
according to the principles of evidence-based medicine.
With this goal in mind, the Dutch Society of Gyneco-
logical Endoscopic Surgery (WGE) initiated the develop-
ment of a guideline for LH. This guideline aims to provide 
gynecologists with an overview of best practices, directly 
applicable for daily practice. The guideline should also 
ensure a minimum quality of care and enhance patient 
safety. This article provides a summary of the main recom-
mendations of the guideline.
Materials and methods
Development of the guideline
The WGE, a working group of the Dutch Society of 
Obstetrics and Gynecology (NVOG), initiated the devel-
opment of the guideline. A guideline working group was 
assembled and consisted of three gynecologists and one 
resident (WJKH, PMG, ART and EMS). The guideline 
was developed in accordance with the Dutch guideline of 
medical specialists [8]. This document, recognized by all 
Dutch medical societies, provides a detailed overview of 
the process of developing an evidence-based guideline 
using the GRADE method [9]. The Appraisal of Guide-
lines for Research and Evaluation instrument (AGREE II), 
an internationally recognized assessment tool, was used in 
a second stage to evaluate the methodological rigor, trans-
parency and quality of the developed guideline [10]. In the 
next subsections, the different steps undertaken to create 
this guideline will be briefly described.
Step 1: Key topic analysis
A brainstorming session was organized by the WGE with 
40 gynecologists, all performing advanced laparoscopic 
procedures. During that meeting, key topics for this guide-
line were determined and transformed into appropriate 
clinical research questions.
Step 2 and 3: Literature selection, data extraction 
and assessment of risk of bias
For each research question, a literature search was set up 
in collaboration with a clinical librarian. PubMed, Medline 
and Cochrane databases were searched up to  1st of March 
2016. Each research question had its own inclusion and 
exclusion criteria. Overall, we first searched for system-
atic reviews. If none were available, we focused on rand-
omized controlled trials (RCTs) and, if necessary, added 
cohort studies as well. Studies from the eligible systematic 
reviews were reviewed to avoid duplicate inclusions. Only 
LH for benign indications and/or low-grade malignancy 
were considered and will hereinafter be referred to as ‘lapa-
roscopic hysterectomy’ (LH). Studies focusing on endo-
metriosis sanitation with concomitant LH as well as high-
grade malignancy were not included. Study reports, letters, 
non-published manuscripts and articles that were not pub-
lished in English were also excluded. After selecting the 
eligible studies, these studies were summarized in evidence 
tables and when possible, extracted for meta-analysis using 
Review Manager (version 5.2 Copenhagen: The Nordic 
Cochrane Centre, The Cochrane Collaboration, 2012). The 
quality of evidence was rated for the different outcomes 
following the GRADE method [9]. The online GRADE 
program was used for this purpose (GRADEpro Guideline 
Development Tool [Software], McMaster University, Ham-
ilton, ON, Canada, 2015, developed by Evidence Prime, 
Inc., available from gradepro.org).
Step 4: Concept guideline
From the initial group of 40 gynecologists who participated 
in the brainstorm session, an expert panel of 18 members 
was selected. The expert panel and the members of the 
guideline met a few times to discuss the research questions 
according to a standard template. The final recommenda-
tions were graded according to the classification used by 
the American Association of Gynecologic Laparoscopists 
(AAGL) which was adapted from the US Preventive Ser-
vices Task Force [11]: Level A: Recommendations are 
based on good and consistent scientific evidence; Level B: 
Recommendations are based on limited or inconsistent sci-
entific evidence; Level C: Recommendations are based pri-
marily on consensus and expert opinion.
The experts wrote the first draft, after which the working 
guideline group merged the different topics into one docu-
ment and finalized the guideline. All experts involved in the 
development of this document approved the guideline in its 
present form.
Step 5: Validation of the guideline
Two independent reviewers, different committees within 
the NVOG as well as the independent Knowledge Institute 
of Medical Specialists (KIMS) reviewed the guideline [12]. 
After approval, our guideline was published on the website 
of the NVOG to allow all Dutch gynecologists to give feed-
back. The guideline will be soon adopted in The Nether-
lands and is valid for 5 years, after which it will be updated. 
If necessary, it will be (partially) updated earlier.




For each of the ten main topics raised during the first brain-
storm session, a literature search was performed. In total 
5233 articles were reviewed and 119 unique articles were 
included in the guideline. In the following section, each 
topic and its best practice recommendations are briefly 
summarized. More detailed information regarding the 
selected literature, the quality of evidence according to the 
GRADE method, the search strings of the different topics 
and the forest plots of the main outcomes, will be published 
in the fall of 2017 on the website of the NVOG (http://
www.nvog.nl).
Topic 1: A comparison of surgical approaches 
for hysterectomy
According to the Cochrane review on this topic, vaginal 
hysterectomy (VH) should be, when technically feasible, 
the approach of first choice, followed by LH and finally 
abdominal hysterectomy (AH) [13]. However, limita-
tions of the Cochrane review are the lack of differentiation 
between the various subtypes of LH (total laparoscopic 
hysterectomy (TLH); laparoscopic-assisted vaginal hyster-
ectomy (LAVH) and robotic hysterectomy (RH)), and the 
inclusion of data from older trials performed in the imple-
mentation period. Because of these potential limitations, 
a new literature search was performed for this guideline, 
specifically comparing TLH to VH. In topic 2, the differ-
ent subtypes of LH were also compared to TLH. To limit 
the bias of a learning curve and reflect current practice, 
we only focused on studies published in the last 15 years 
(from 1st of January 2000 up to 1st of March 2016).
TLH versus VH
As can be observed in Table 1, VH was associated with a sig-
nificantly shorter operative time, a lower risk of conversion 
and a lower risk of vaginal cuff dehiscence. Patients in the 
TLH group had lower postoperative pain scores and required 
analgesia for a shorter period. The other outcomes were simi-
lar, and notably the risk of ureter and bladder injury did not 
differ between the groups, in contrast to what was found in pre-
viously published studies [13]. Many factors, such as patient 
and surgeon characteristics, influence the choice of approach. 
Our results show that since the implementation of LH, the dif-
ferences in clinical outcomes between VH and TLH have been 
minimized. However, when both approaches are feasible, VH 
is still associated with more relevant benefits compared to LH 
and should therefore be the approach of first choice.
Recommendations
• When both approaches are feasible, VH still 
offers the most relevant benefits and should be the
 approach of first choice. (level A-C, table 1)








or odds ratio (OR) 
95% Confidence 
interval 
Operative time (RCTs only)    +36 min [5.90, 65.13] 
Blood loss (RCTs only)    -38 mL [−96.7, 21.31] 
Length of stay (RCTs only) −0.32 days [−0.85, 0.20]
VAS 24 h postoperatively −1.1 VAS score [−1.74, −0.42]
Days of analgesia use −0.64 days [−1.06, −0.22] 
Costs 3889.9 US dollars [2120.3,8900.0]
Major complications OR 1.25 [0.60, 2.61]
Vaginal cuff    OR 6.75 [2.44,18.69] 
Ureter/bladder injury    OR 0.81 [0.31, 2.06] 
Minor complications OR 0.79 [0.52, 1.18]
noisrevnoC  OR 3.77 [2.14, 6.65] 
Conversion (RCTs only)    OR 1.00 [0.10, 9.89] 
Sexual dysfunction – –
Patient satisfaction – –
Detection of intra-operative 
pathology 
   – – 
Cutaneous scars – –
TLH total laparoscopic hysterectomy, VH vaginal hysterectomy; RCT randomized controlled trial
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Topic 2: A comparison of the different subtypes of LH
TLH versus LAVH
The percentage of hysterectomies performed using the LAVH 
technique is decreasing. Currently, LAVHs account for 3% of 
the LHs in The Netherlands [14]. Based on current literature, 
no clinically relevant differences were observed between the 
two approaches. From the meta-analysis performed on this 
topic, we concluded that the mean differences of 19.7  min 
(13.08, 26.37) for operative time and 82 ml (−151.95, −12.07) 
for intra-operative blood loss were not deemed to be clinically 
relevant. Although the risk of vaginal cuff dehiscence was 
higher after TLH [OR 2.97 (1.43, 6.18)], the incidence of cuff 
dehiscence is still low. Furthermore, no overall difference was 
observed for major complications [OR 1.06 (0.66, 1.68)].
Recommendations
• The surgeons should use the technique that 
they best mastered, as no particular preference  
for TLH or LAVH was observed. (level B)
TLH versus RH
The results of the meta-analysis showed no clinically rel-
evant differences between TLH and RH for most surgical 
and patient outcomes. Regarding the costs of the procedure, 
no meta-analysis could be performed because of incom-
plete data. Yet, all studies showed that LH was significantly 
less expensive with mean differences of 1.916 US dollars 
[15], 3.049 US dollars [16] and 11.214 US dollars [17].
Recommendations
• For LH, RH has no advantages and 
is associated with higher costs. (level B)
TLH versus supra‑cervical laparoscopic hysterectomy 
(SLH)
The results of the meta-analysis for this topic are sum-
marized in Table  2. Despite the fact that most included 
studies were underpowered and nonrandomized, the expert 
panel concluded that no major differences were observed 
between the two procedures, except potentially for com-
plications. In addition, it is important to realize that in 
the SLH group morcellation is always necessary, which 
could result in more (mini)laparotomies (topic 8). Finally, 
the pre-operative cervix cytology, the impact of follow-up 
screening and the increased risk of cyclic bleeding should 
also be considered when weighing the pros and cons of the 
two procedures.
Recommendations
• No clinically relevant surgical differences  
were found between TLH and SLH, except  
potentially for complications. (level B) 
• It is important to counsel a patient about the  
pros and cons of both approaches (Table 5). (level C) 
• Shared decision making is recommended. (level C)
Topic 3: What is the added value of pre‑operative 
treatment—gonadotropin‑releasing hormone agonists 
(GnRHa) or ulipristal—prior to LH for uterine 
fibroids?
This topic evaluated the effect of pre-operative medi-
cal treatment (GnRHa and/or Ulipristal) on complica-
tion risk, conversion risk, intra-operative blood loss and 
operative time during LH. The available evidence was 
limited, especially because many studies did not differ-
entiate between the different approaches of hysterectomy 
(abdominal, vaginal and laparoscopic). Based on the 
selected literature, we concluded that there is currently no 
need to standard pre-operatively treat patients who desire 
LH for uterine fibroids as the advantages are marginal. 
However, substantial volume reduction has been demon-
strated in some studies (2 weeks in gestational age [18], 
including a 47% reduction in the study of Donnez et  al 
[19]). Therefore, for each patient a well-considered deci-
sion should be made, taking into account the expected 
volume reduction and hence the possibility for a mini-
mally invasive approach, the side effects and the costs of 
treatment.
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Recommendations
• Standard pre-operative treatment of patients  
with fibroids does not seem advisable as  
the advantages are marginal. (level B) 
• When uterine volume reduction is desirable,  
especially to increase the possibility for a minimally  
invasive approach, pre-operative treatment with  
GnRHa should be considered. (level B) 
• If prescribed, GnRHa should be given 
for at least three months. (level C)
Topic 4.1: Which patient characteristics influence 
surgical outcomes during laparoscopic hysterectomy?
To answer this research question, one systematic review 
was selected [20]. In this review, associations between 
patient characteristics and surgical outcomes of LH were 
described based on 85 articles (four RCTs, 29 prospective 
cohort studies, 47 retrospective cohort studies and five 
case-control studies).
Recommendations
• It is necessary to discuss with patients the fact 
that high BMI, large uterine weight and/or previous
surgeries (e.g., intra-abdominal adhesions) influence  
intraoperative blood loss, operative time and complication  
and conversion risks (level A)
Topic 4.2: What is the added value of bimanual 
examination and medical imaging (ultrasound, MRI) 
prior to hysterectomy?
Pre-operative gynecological examination (speculum 
and bimanual examination) gives surgeons informa-
tion on uterine mobility and an appropriate estima-
tion of the uterine weight. These findings are relevant 
for determining the operability of the patient (i.e., best 
surgical approach). Additionally, an ultrasound is use-
ful for detecting potential intra-abdominal pathologies. 
The expert panel agreed that an MRI is not necessar-
ily superior to ultrasound for hysterectomy with benign 
indications.












Operative time    +7.56 min [12.82, 2.31] 
Blood loss  −14.09 mL [7.66, −35.84] 
Length of stay +0.15 days [0.20, 0.10]
Return to normal activities 3.61 days [7.72, −0.49]
Major complications     OR 2.13 [1.20, 3.79] 
Minor complications    OR 2.42 [1.42, 4.11] 
Ureter injuries OR 1.46 [0.45, 4.78]
Bladder injuries    OR 5.00 [1.82, 13.76] 
Postoperative hemorrhage    OR 5.62 [2.18, 14.52] 
Conversion OR 1.67 [1.15, 2.41]
Cyclic bleeding 0 versus 14.3% –
Cervix excision    0 versus 0.5% – 
Pelvic prolapse  Uncleara  – – 
Sexual dysfunction – –
Patient satisfaction    – – 
TLH total laparoscopic hysterectomy, SLH supra-cervical hysterectomy, RCT randomized controlled trial
a Lethaby et  al (systematic review): no difference in rate of pelvic prolapse; Berner et  al (RCT): higher risk of (asymptomatic) prolapse 
12 months after TLH (10% versus 32%)
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Recommendations
• A vaginal examination (speculum and bimanual examination)  
should always be performed to estimate the operability  
of a patient and predict the best surgical approach. (level C) 
• A MRI is not a standard requirement for LH. 
Ultrasound is sufficient to detect potential additional  
pathology. (level C)
Topic 5: Which instrument is the most appropriate: 
bipolar electrothermical energy or ultrasonic energy?
The aim of this topic was to compare bipolar electro-
thermical energy with ultrasonic energy, particularly 
with respect to patient safety. Electrothermical energy 
with monopolar instruments was not included in this 
topic.
Because of the rapid development of (new) instruments, 
studies quickly become outdated. The differences observed 
in surgical outcomes between instruments (bipolar electro-
thermical energy versus ultrasonic energy) were probably 
also influenced by surgeon’s experience and preference 
as well as by the surgical task performed. As differences 
in clinical findings were small, the expert panel concluded 
that there was no preference of one instrument over the 
other. The expert panel emphasized that experience with 
a specific instrument is valuable and essential for a safe 
procedure.
Recommendations
• Surgeons should use the instruments that  
they have the most experience with. (level C) 
• Sufficient knowledge of the used technique 
is essential. (level C)
Topic 6: What are the indications for a uterine 
manipulator and what is its role in preventing ureter 
injuries?
Recommendations
• Although there is no evidence that a  
uterine manipulator prevents ureter injuries,  
it is recommended during LH, particularly  
for better overview of the anatomy. (level C) 
• There is no preference for a specific 
manipulator. (level B)
Topic 7: Which techniques prevent and/or detect ureter 
injuries during LH?
Ureter stents
As limited evidence was available for benign LH, the 
search was extended to articles included oncological and 
endometriosis/DIE cases. Ureter stents do not seem to pre-
vent ureter injury as no significant difference was observed 
for ureter injuries between the group with and the group 
without stents [OR 2.45 (0.28; 21.29)]. Standard stent 
placement could also result in unnecessary complications. 
Stents are, however, easy to insert and improve the identifi-
cation of the ureters. In the Delphi study by Janssen et al., 
the experts did not reach consensus regarding the additional 
value of ureter stents during LH [21].
Recommendations
• Standard insertion of ureter stents during  
LH is not recommended. (level B) 
• In case of expected distorted anatomy  
(e.g., oncology, DIE), stents can be considered. (level C) 
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Cystoscopy
Cystoscopy appears to be safe and results in limited exten-
sion of the operative time (mean additional time 13 min). 
When the overall risk of bladder and/or ureter injuries is 
below 2%, a standard cystoscopy is not cost-effective for 
LH [22]. The American Association of Gynecologic Lapa-
roscopists (AAGL) have recommended the standard use of 
a cystoscopy after LH [23]. The expert panel, on the other 
hand, concluded that based on available evidence, including 
incidence data and data on cost-effectiveness, there is insuf-
ficient justification to recommend routine cystoscopy after 
LH. However, the threshold to perform a cystoscopy should 
be low. When injuries are suspected intra-operatively, addi-
tional diagnostics during surgery is recommended and for 
this a cystoscopy can be of additional value. At last, one 
should be aware that a normal cystoscopy does not exclude 
the presence of (lateral thermal) injury, especially for ureter 
injuries.
Recommendations
• A standard cystoscopy after LH is not recommended  
as the additional value of it has not been proven. (level B) 
• When a urinary tract injury is suspected intra-operatively,  
a low threshold for additional diagnostics is recommended 
(cystoscopy and/or consultation of the urologist). (level B) 
Intra‑ and postoperative advice for ureter injuries
Recommendations
• It is important to keep in mind that ureter injuries  
can become manifest even long after initial surgery
and that symptoms can be nonspecific. (level A) 
• A good knowledge of the pelvic anatomy 
is recommended. (level C)
Topic 8: What are the current views regarding power 
morcellation?
Based on the available evidence, we concluded that the 
incidence of unexpected sarcoma varies between 1:350 and 
1:2000 [24] and increases with age [25]. Other risk fac-
tors associated with uterine sarcomas are the following: 
African race, Tamoxifen use, previous radiotherapy in the 
pelvic area, HLRCC syndrome and retinoblastoma in the 
past medical history [25]. The exact impact of malignant 
spill on overall survival is uncertain, but the risk of upstag-
ing due to morcellation has been estimated to be between 
15 and 64% [24]. One of the proposed solutions to mini-
mize spillage of occult malignancy or parasitic myomas is 
the use of containment bags during morcellation. Although 
these bags are certainly not optimal yet, they are theoreti-
cally able to prevent spread of (malignant) tissue in the 
abdomen. Gynecologists performing LH should thoroughly 
counsel their patients and should acquire the skills of in-
bag morcellation so that they can offer all the options to 
their patients. The ESGE developed a flow chart allowing 
patients to be classified into a low- or high-risk category for 
sarcomas based on their risk factors and ultrasound results 
[25]. However, as long as the nature of the uterine mass 
cannot be diagnosed pre-operatively with certainty, such 
classifications are not entirely reliable.
Recommendations
• Counsel the patient about the risks of morcellation
(risk of spill of potential malignant cells and  
of parasitic fibroids). (level B) 
• Open morcellation is not recommended when  
hypervascularisation is observed on ultrasound  
and/or MRI in combination with necrosis and/or  
other risk factors for sarcomas. (level C) 
• When uncontained morcellation is estimated 
to be unsafe, perform ‘contained morcellation’  
or a (mini)laparotomy to obtain the specimen. (level C)
Topic 9: When is the best moment to remove 
the urinary catheter after LH?
Using a urinary catheter during LH is recommended [26] 
but the best moment to remove it is unclear. Although 
evidence was limited, particularly for LH, it seems safe 
to remove the urinary catheter immediately after hyster-
ectomy. Insufficient evidence was available to determine 
if leaving the catheter for 6 h offers better outcomes than 
immediate removal. Leaving the catheter longer than 6 h 
does not seem to offer any benefits whereas it does increase 
the risk of urinary tract infection and prolonged hospital 
stay.
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Recommendations
• It is recommended to remove the urinary 
catheter within six hours after LH. (level C)
Topic 10: What advice and/or interventions are helpful 
to promote postoperative recovery?
Sufficient evidence is available to state that LH is associ-
ated with a shorter hospital stay and a quicker recovery 
than AH [13]. However, research has shown that the time 
to return to normal activities after LH (i.e., time to return 
to work) takes overall longer than would be expected [27]. 
To maximize the benefits of minimally invasive surgery, it 
is important to adequately guide patients during recovery 
at home. The complexity of the surgery, the pre-operative 
expectations of the patient and their pre-operative mental 
status seem to directly influence the patients’ risk of pro-
longed absence due to sickness. Therefore, it is important 
to pre-operatively discuss expectations with the patients. In 
addition, structured and specific advice results in quicker 
recovery and E-Health programs can be used for that pur-
pose, Finally, specific advice is needed for each type of hys-
terectomy as advice is not generalizable for all approaches 
of hysterectomy [28].
Recommendations
• Specific recovery advice is recommended 
since it will result in quicker recovery. (level B)
• E-health programs are promising tools 
to stimulate patient recovery. (level B)
• It is important to discuss preoperatively the 
expectations of patients regarding the surgery  
and recovery. (level B)
Discussion and conclusion
This guideline serves as a summary of best practices of LH, 
and it should provide clinicians with relevant and evidence-
based information for daily practice. In other countries such 
as Germany, guidelines on hysterectomy have been devel-
oped as well with similar recommendations [29]. Besides 
the fact that such guidelines provide surgeons with an 
overview of the most relevant topics, studies have shown 
that standardization of care and subsequent guideline 
compliance is associated with better outcomes and reduced 
medical liability [30, 31]. Regarding the medico-legal con-
sequences of this guideline, it is probable that in the future 
it may be used for litigation in The Netherlands. Deviating 
from this standard of care is obviously allowed, provided 
that the motivation is thoroughly documented.
Regarding the methodology of this guideline, we 
focused on systematic reviews and RCTs. If insufficient 
evidence was available from the RCTs, we added cohort 
studies to our analysis. A limitation of this approach is 
that it increases the methodological and clinical hetero-
geneity. For instance, by including cohort studies, differ-
ences in baseline characteristics might exist, which could 
have influenced the outcomes. On the other hand, this 
method can also been seen as a strength because for rare 
events RCTs are often not the best study design as they 
are often underpowered. During the development of this 
guideline, we realized that, although GRADE is currently 
a well-established instrument to assess the quality of evi-
dence [9], it has its limitations as well. The main problem 
we encountered was that for many topics the available 
evidence was limited and therefore the quality of the evi-
dence was instantly downgraded to ‘low’ or ‘very low’. 
This point has been raised previously by other authors 
[32] and the GRADE working group [33] has stated 
that on occasion even low available evidence can lead to 
strong recommendations. The GRADE working group 
has also emphasized that clinical and cultural settings are 
of influence and might result in (slightly) different recom-
mendations across countries [33]. Therefore it is essen-
tial to choose an expert panel that is well-supported [33]. 
As the development of our guideline was initiated by the 
Dutch medical society itself, we believe we had support 
from the entire country, especially since the panel was a 
good representation of all Dutch gynecologists.
Conclusion
The guideline for LH serves as guidance for gynecolo-
gists performing LHs. The recommendations in this best 
practice review should enhance quality of care, minimize 
(unfavorable) practice variations at the (inter)national 
level and thereby increase patient safety.
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